Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,631 | 4,455 | 3,255 | 3,289 | 2,019 |
| Marketable Securities | 2,411 | 2,273 | 4,867 | 298 | 414 |
| Receivables | N/A | N/A | 73 | 112 | 321 |
| Other current assets | 79 | 102 | 0 | 2,507 | 0 |
| TOTAL | $6,121 | $6,830 | $8,195 | $6,206 | $2,754 |
| Non-Current Assets | |||||
| PPE Net | 2 | 2 | N/A | N/A | 10 |
| Intangibles | 380 | 380 | 380 | 380 | 253 |
| TOTAL | $382 | $382 | $380 | $380 | $263 |
| Total Assets | $6,503 | $7,212 | $8,575 | $6,586 | $3,017 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 254 | 232 | 253 | 300 | 330 |
| TOTAL | $254 | $232 | $253 | $300 | $330 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,637 | 0 | 0 | 2,667 | 0 |
| TOTAL | $2,637 | $N/A | $N/A | $2,667 | $N/A |
| Total Liabilities | $2,891 | $232 | $253 | $2,967 | $330 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 5,142 | N/A |
| Common Shares | 13,182 | 13,182 | 13,182 | 13,182 | 6,624 |
| Retained earnings | -155,605 | -153,930 | -152,588 | -155,645 | -154,904 |
| Other shareholders' equity | 20 | 20 | 20 | 67 | 183 |
| TOTAL | $3,612 | $6,980 | $8,322 | $3,619 | $2,687 |
| Total Liabilities And Equity | $6,503 | $7,212 | $8,575 | $6,586 | $3,017 |